Verified peer comparison
Regeneron Pharmaceuticals, Inc. vs Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock Financial Comparison
Regeneron Pharmaceuticals, Inc. versus Northern Trust Corporation - Depositary…
Direct answer
Regeneron Pharmaceuticals, Inc. and Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Regeneron Pharmaceuticals, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Regeneron Pharmaceuticals, Inc. Revenue
- 14,342,900,000 USD
- Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock Revenue
- 14,299,900,000 USD
- Regeneron Pharmaceuticals, Inc. Operating income
- 3,577,900,000 USD
- Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock Operating income
- 2,331,500,000 USD